A case report of glecaprevir/pibrentasvir-induced severe hyperbilirubinemia in a patient with compensated liver cirrhosis

RATIONALE: Glecaprevir/pibrentasvir, a pan-genotypic and ribavirin-free direct acting antiviral agent regimen, has shown significant efficacy and very few serious complications. However, as the drug metabolizes in the liver, it is not recommended in patients with decompensated liver cirrhosis. Herei...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jae Hyun, Kim, Sun Min, Kang, Gaeun, Kim, Hee Joon, Jun, Chung Hwan, Choi, Sung Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775421/
https://www.ncbi.nlm.nih.gov/pubmed/31574875
http://dx.doi.org/10.1097/MD.0000000000017343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775421/
https://www.ncbi.nlm.nih.gov/pubmed/31574875
http://dx.doi.org/10.1097/MD.0000000000017343

Ejemplares similares